"Through CPACT, GlaxoSmithKline will benefit from developments in process analytical chemistry, signal interpretation and process control.
We will gain early access to and technical transfer of innovative technology, including software for process simulation and plant management.
CPACT will enhance professional development of GlaxoSmithKline staff and provide access to trained and motivated graduates.
Above all, it is a forum for networking and benchmarking in process analysis and control engineering.
"GlaxoSmithKline is delighted to be involved in the CPACT collaboration.
As our core business centres on the discovery and development of novel, ethical pharmaceutical products, we feel that CPACT provides expertise and resource which would not ordinarily be available within our organisation."